Price T Rowe Associates Inc Rocket Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,169,448 shares of RCKT stock, worth $55.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,169,448

Previous 2,943,160 7.69%

Holding current value

$55.7 Million

Previous $79.3 Million 13.94%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $4.68 Million - $6.05 Million	226,288 Added 7.69%	3,169,448 $68.2 Million
Q1 2024 May 15, 2024	BUY	$26.16 - $30.74 $8.22 Million - $9.66 Million	314,086 Added 11.95%	2,943,160 $79.3 Million
Q4 2023 Feb 14, 2024	SELL	$16.78 - $31.94 $148,956 - $283,531	-8,877 Reduced 0.34%	2,629,074 $78.8 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $7.82 Million - $12.5 Million	519,145 Added 24.5%	2,637,951 $54.1 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $4.18 Million - $5.94 Million	251,824 Added 13.49%	2,118,806 $42.1 Million
Q1 2023 May 15, 2023	SELL	$15.79 - $22.6 $304,873 - $436,360	-19,308 Reduced 1.02%	1,866,982 $32 Million
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $3.82 Million - $5.61 Million	246,647 Added 15.04%	1,886,290 $36.9 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $2.87 Million - $4.28 Million	232,294 Added 16.51%	1,639,643 $26.2 Million
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $8.72 Million - $18.2 Million	-1,095,037 Reduced 43.76%	1,407,349 $19.4 Million
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $4.07 Million - $7.33 Million	309,492 Added 14.11%	2,502,386 $39.7 Million
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $14.9 Million - $24.9 Million	-691,532 Reduced 23.97%	2,192,894 $47.9 Million
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $12.8 Million - $22.9 Million	-468,259 Reduced 13.97%	2,884,426 $86.2 Million
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $9.7 Million - $11.6 Million	-246,150 Reduced 6.84%	3,352,685 $148 Million
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $5.18 Million - $7.88 Million	119,514 Added 3.43%	3,598,835 $160 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $81.1 Million - $207 Million	3,479,321 New	3,479,321 $191 Million

Others Institutions Holding RCKT

# of Institutions

194

Shares Held

92.3M

Call Options Held

222K

Put Options Held

111K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.33B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Rocket Pharmaceuticals, Inc. Transaction History